Abstract: Inflammatory bowel disease (IBD) is a multifactorial disease with an unknown etiology characterized by oxidative stress, leukocyte infiltration and a rise in inflammatory cytokines. In this study, we have investigated the effects of silymarin, a mixture of several flavonolignans with established antioxidant and anti-inflammatory properties, on trinitrobenzene sulphonic acid (TNBS)-induced colitis in rats. Experimental colitis was induced in male Wistar-albino rats by delivering TNBS to the distal colon. All the medicines were administered by gavage for seven days. Thirty-six male rats were divided into six groups containing six rats in each one. Control rats received only TNBS. In the treated groups, animals were given different doses of silymarin (40, 80, and 160 mg/kg). Dexamethasone (1 mg/kg) was used as the positive treatment. Colonic status was investigated seven days post induction of colitis through macroscopic, histological, and biochemical analyses. Amelioration of the morphological signs including macroscopic damage, necrotic area, and histology were seen subsequent to treating animals with silymarin. These observations were accompanied by a significant reduction in the degree of both neutrophil infiltration, indicated by decreased myeloperoxidase activity, and lipid peroxidation, as measured by a decline in malodialdehyde content in inflamed colon as well as a decrease in levels of inflammatory cytokines (TNF-α and IL-1β). The results of the present study reveal that the beneficial effect of silymarin in bowel cells is mediated through its anti-oxidant and anti-inflammatory potentials.
Introduction
Idiopathic inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is a chronic inflammatory disorder of the gastrointestinal tract with unknown etiology [1] . Many factors have been suggested to be responsible for the initiation and/or perpetuation of this inflammatory condition such as genetic and environmental factors, impaired immunity, and microbial factors [2, 3] . One major factor in initiation or development of IBD is toxic stress, referring to oxidative and nitrosative stress. Free radicals, including reactive oxygen species (ROS) and reactive nitric oxide species are produced as by-products of normal biochemical processes in the cell [4] . These highly reactive molecules can react with polyunsaturated fatty acids (PUFs) in the cell membrane and lead to lipid peroxidation and damage to the cell membrane. Moreover, they can damage cellular macromolecules like DNA, RNA and proteins, and lead to cell death [5, 6] . Many medical therapies have been proposed for IBD like salicylates, glucocorticoids, and immunosuppressives [7, 8] but its medical management remains challenging and investigations on novel treatments are required. The main challenge is overcoming the limitations in using these medical agents. In fact, low efficacy and high incidence of side effects, alongside unreachable remission, are the major difficulties in management of IBD [9] . Recent investigations have suggested novel strategies. Beneficial effects of N-Acetyl cystein have been proved in this condition [10] . Also, nicorandil as a unique potassium channel opener, has been recently shown to be effective in management of IBD in rats [11] . Recently, the effectiveness of many pharmacotherapeutic agents including antibiotics [12] [13] [14] [15] , probiotics [16, 17] and 5-aminosalicylates [18] [19] [20] has been meta-analyzed. In addition, using herbal extracts as a new strategy for management of IBD is currently in the center of attention [21] [22] [23] [24] .
One of the most controversial herbal extracts in the aspect of gastrointestinal diseases is silymarin. Silymarin, a complex of four flavonolignans named silybin, isosilybin, silydianin and silychristin, is extracted from Silybum marianum (milk thistle) seeds. Many investigations have shown therapeutic effects, associated with the use of silymarin, for instance, silymarin has strong anti-oxidant properties [25] and has been shown to have free radical scavenging traits alongside increasing glutathione levels. Researches have revealed that silymarin is able to enhance the activity of anti-oxidant enzymes such as superoxide dismutase and catalase. In addition, silymarin has been found to interact with components of the cell membrane and averts any deformity in the lipid content of membranes. These actions make silymarin a proper candidate for management of toxic stress [26] . Moreover silymarin has been reported to have many anti-inflammatory effects including mast cell stabilization, inhibition of neutrophil infiltration [27] , decreasing adhesion molecules [28] and downregulation of leukoterienes and prostaglandins synthesis by inhibition of cyclooxygenase-II [27, 29, 30] . In addition, silymarin inhibits interleukin (IL)-6 and transforming growth factor (TGF)-β which are key cytokines in differentiation of regulatory T cells CD4+CD25-Foxp3-to T helper (Th) 17 cells. Th17 cells are important sources of inflammatory cytokines like tumor necrosis factor (TNF)-α and IL-6 [31] .
Silymarin has inhibitory effects on inducible nitric oxide (NO) synthase (iNOS) activity [32] . Many researches have shown that constitutive production of NO from endothelial NO synthase (eNOS) is advantageous in acute colitis, although chronic overproduction of NO from iNOS is associated with perpetuation of inflammatory process [32] [33] [34] . Furthermore, silymarin diminishes the release of proinflammatory cytokines like IL-1, IL-6, interferon (IFN)-γ and TNF-α from activated immune cells and consequently lessens activation of other immune cells following their release [27] . Silymarin is a potent inhibitor of nuclear factor-kappa B (NF-κB) activation, the main mediator of TNF-α effects [35] . Finally, silymarin possesses immunomodulatory [27] , anti-angiogenesis [28] and anti-fibrotic functions [29] . These conspicuous characteristics of silymarin have led to some investigations on gastrointestinal diseases in which the beneficial effects of silymarin have been shown, including hepatic impairments like primary sclerosing cholangitis and liver cirrhosis [36, 37] .
Because of the notable anti-oxidative, antiinflammatory, and immunomodulatory properties of silymarin, and factors involved in initiation and progression of IBD, we examined the potential protective effects of silymarin in remission of an immune based animal model of IBD. 
Experimental Procedures

Chemicals
Animals
In this study male Wistar-albino rats, weighing between 220 and 230 g were used. Animals were maintained under standard conditions of temperature (23±1ºC), relative humidity (55±10%), and 12/12 hours light/dark cycle, and fed with a standard pellet diet and water ad libitum. They were housed individually in standard polypropylene cages with a wire mesh top. All ethical themes concerning animal experiments were considered carefully and the experimental protocol was approved by the Ethic Committee of TUMS.
Experimental design
Six groups of male rats containing six rats in each group were considered in this study. Colitis was induced by rectal administration of TNBS in five groups and the resting group, sham group, received normal saline instead of TNBS. The five remaining groups receiving TNBS were: control group that received no treatment, dexamethasone-treated group (Dexa) receiving dexamethasone (1 mg/kg), and silymarin-treated groups (Sil) in doses of 40, 80, and 160 mg/kg. All the medications were prepared in a volume of 0.4 ml per 200 g of body weight and administered by gavage for seven days, with the day of induction of colitis considered as the first day.
Induction of colitis
All the rats were fasted for 36 hours before the induction of colitis. Rats were anesthetized with administration of 45 mg/kg pentobarbital sodium intraperitoneally [38] , which was repeated if necessary. At first, a mixture of 30 mg TNBS in 0.25 ml of ethanol 50% was used intrarectally for induction of colitis [39] . Due to a high rate of mortality, the method was modified to the following mode, in which macroscopic and microscopic evidence showed a proper induction of colitis: the rats were positioned on their right side and 0.3 ml of a mixture containing 6 volume of 5% TNBS plus 4 volume of 99% ethanol was instilled intracolonically (10 mg TNBS per rat) using a rubber cannula (8 cm long). Following instillation of TNBS, rats were maintained in a supine Trendelenburg position in order to prevent anal leakage of TNBS. Administration of medications was performed for the following seven days. On the eighth day, animals were anaesthetized using pentobarbital sodium; the abdomen was dissected open and the colon was removed. An overdose of ether inhalation was used to sacrifice all the animals at the end of the procedure. The pieces of colons were cut open in an ice bath, cleansed gently using normal saline and macroscopically scored. Pieces were cut into two pieces, one piece for histopathology assessment (maintained in 5 ml formalin 10% as fixater) and one piece for measuring biomarkers. The pieces for analysis of biomarkers were weighed and maintained in -20º C for 24 hours. Then, the colonic samples were homogenized in 10 volume ice cold 50 mM potassium phosphate buffer (pH 7.4). One-hundred µl of each sample was taken for Ferric Reducing Anti-oxidant Power (FRAP) assay and kept at -80ºC until analysis. The remained homogenates were then sonicated and centrifuged for 30 min at 3500 g. The plates were separated and the supernatants were transferred into several microtubes for separate biochemical assays and all were kept at -80ºC until analyses [11] .
Score
Microscopic criteria Two or more sites of ulceration and extending more than 1 cm along the length of colon
5-8
Damage extending more than 2 cm along the length of colon and the score is enhanced by 1 for each increased cm of involvement Table 1 . Macroscopic scoring of colonic damage.
Macroscopic and microscopic assessment of colonic damage
The severity of colonic damage was evaluated using the colon macroscopic scoring as described in Table 1 . In addition, the fixed segments in formalin 10% were embedded in paraffin and stained with hematoxyllin and eosin. The scoring was performed by an observer blind to the treated groups as described previously ( Table 2 ).
Determination of tumor necrosis factor-α and interleukin-1β
Quantitative detection of TNF-α and IL-1β levels in colon tissues were performed using an enzyme-linked immunosorbaent assay rat specific ELISA kit. The absorbance of the final colored product was measured in 450 nm as the primary wave length and 620 nm as the reference wave length. TNF-α and IL-1β levels were expressed as pg/mg protein of tissue.
Ferric Reducing Anti-oxidant Power (FRAP) assay
Total anti-oxidant capacity of tissue was evaluated in tissues by measuring the ability to reduce Fe 3+ to Fe 2+ .
Interaction of TPTZ with Fe
2+ , results in formation of a blue color, with a maximum absorbance at 593 nm as described in our previous study [40] . Data was expressed as µM ferric ions reduced to ferrous form per g of tissue.
Myeloperoxidase activity measurement
UV spectrophotometer was used to measure myeloperoxidase (MPO) activity in colon tissue. The absorbances were measured for 3 minutes in 460 nm as described previously [21] . MPO results were reported as U/mg protein of tissue.
Thiobarbituric acid-reactive substance assay
Lipid peroxidation occurs because of toxic stress and can lead to serious cellular damages. MDA, the main byproduct of PUFs oxidation, is known as a biomarker of lipid peroxidation and its concentration was assessed in colon cells using thiobarbituric acid-reactive substance (TBARS) assay as described previously [41] . The data was reported as µM/g of tissue.
Total protein of colon homogenate
Total protein (TP) of tissue were measured according to Lowry method. In this method BSA is used as the standard in different concentration. Results were reported as mg/ml of homogenized tissue [42] .
Statistical analysis
Results are expressed as mean ± standard error of the mean (SEM). The data was analyzed by one-way ANOVA followed by Tukey's post hoc test for multiple comparisons to ensure the variances of data are distributed properly. A P-value of less than 0.05 was considered significant.
Results
Macroscopic and microscopic evaluation of colonic damage
Treatment of animals with TNBS/ethanol caused severe inflammation, ulceration, dilatation, adhesion and wall thickening whereas colons of sham group were normal (P<0.01). Administration of silymarin, reduced colonic damage in a dose-dependent manner (P<0.01). Dexamethasone improved macroscopic scores significantly in colitis rats (P<0.01). Microscopic evaluation of control group showed highly severe, intense transmural inflammation and/or diffuse necrosis, whereas in sham group features of colons were within normal limits (P<0.01). Histological examination of Sil-160 group showed a mild inflammation of mucosa. In Sil-80 group, mucosal inflammation, submucosal edema, and inflammatory cell infiltration were observed (P<0.01). Sil-40 group showed moderate mucosal and submucosal inflammation, crypt distortion and goblet cell depletion. Minimal mucosal inflammatory cell infiltration observed in histological evaluation of Dexa group colons ( Table 3 and Figure 1 ).
Colonic TNF-α levels
Inflammatory condition caused a significant elevation in terms of TNF-α levels in control group when compared to sham (P<0.01). Its levels where significantly decreased by administration of silymarin at dose of 160 mg/kg to colitis rats (P=0.00), while TNF-α levels did not improved in Sil-40 (P=0.84) and Sil-80 (P=0.95) compared to control group. Also, no significant difference was observed between Sil-40 and Sil-80 groups (P=0.99). In Sil-160 group, TNF-α level was close to that of Dexa group (P=0.86); although, its level was significantly higher in Sil-40 and Sil-80 compared to Dexa (P<0.01) (Figure 2 ).
Colonic IL-1β levels
IL-1β level was higher in control group when compared to sham group (P<0.01). Administration of silymarin significantly decreased its level in three groups of Sil-40, Sil-80 and Sil-160 when compared to control group (P<0.01). Although, there was not a significant difference in terms of IL-1β levels in Sil-40 compared to Sil-80 (P=0.9) and Sil-80 compared to Sil-160 (P=0.33), IL-1β levels were significantly lower in Sil-160 than Sil-40 (P<0.05). Data show that IL-1β levels were significantly higher in Sil-40, Sil-80 and Sil-160 compared to Dexa (P<0.01) (Figure 3) . 
Colonic anti-oxidant power as FRAP
Colonic damage and inflammation caused a significant reduction in FRAP value of control group when compared to normal rats in sham group (P<0.01). FRAP values were significantly increased following administration of silymarin in all three doses (P<0.01), while its value was highest in Sil-160 compared to other silymarin-treated groups (P<0.01). In addition, there was a significant difference in terms of FRAP value between Sil-40 and Sil-80 (P<0.01). Although FRAP value in Sil-80 and Sil-160 was significantly higher than those of Dexa group (P<0.01), there was not a significant difference between Sil-40 and Dexa groups (P=0.98) (Figure 4 ).
Colonic MPO activity
MPO activity in control group was significantly higher than that in sham group (P<0.01). Treatment of animals with silymarin significantly reduced its activity when compared to control group (P<0.05); this reduction was most significant at the dose of 160 mg/kg (P=0.00). There was not a significant difference in terms of MPO activity in Sil-40 compared to Sil-80 (P=0.8) and Sil-80 compared to Sil-160 (P=0.27). Furthermore, administration of silymarin at dose of 160 mg/kg resulted in values near those gained by Dexa (P=0.8). However, MPO activities in Sil-40 and Sil-80 were significantly higher than Dexa (P<0.05) ( Figure 5 ).
Colonic lipid peroxidation levels as TBARS
There was a significant increase in TBARS levels resulting from the treatment of animals with TNBS/ ethanol in control compared with sham (P<0.01). TBARS levels decreased significantly in Sil-40, Sil-80, and Sil-160 compared to control (P<0.01), whereas its levels were lowest in Sil-160 compared to two other silymarin-treated groups (P<0.05). There was a significant difference in terms of TBARS levels between Sil-40 and Sil-80 (P<0.008). Its level in Sil-160 was significantly lower than Dexa group (P<0.01), while TBARS value in Sil-80 nearly approximated the values gained in Dexa group (P=0.23). Finally, administration of silymarin in dose of 40 mg/kg resulted in a TBARS value which was significantly higher than Dexa group (P<0.01) (Figure 6 ).
Discussion
Results of this study demonstrate the beneficial effects of silymarin in an experimental model of colitis induced by TNBS. Silymarin dramatically improved colonic macroscopic and histological damages, reduced levels of proinflammatory cytokines, lipid peroxidation and neutrophil sequestration and finally increased anti-oxidant power of tissue in a dose-dependent manner. An appropriate animal model of IBD is one that exhibits all the characteristics of a typical human IBD, including macroscopic, histopathological and biochemical alternations along with covering acute and chronic symptoms. In TNBS-induced colitis the mucosal barrier is destructed by means of ethanol enema and TNBS acts as a hapten and its administration induces a delayed-type hypersensitivity reaction which results in a colitis. This experimental model is very similar to human IBD and has been extensively used for clinical investigations [43] [44] [45] .
Amongst the immunomodulatory factors in intestine, it is thought that the cytokines play an important role. An imbalance between proinflammatory and antiinflammatory cytokines is one of the major factors underlying the pathogenesis of IBD. It has been shown that two proinflammatory cytokines, TNF-α and IL-1β are overproduced during the course of inflammation in human IBD [46] [47] [48] and in TNBS-induced colitis [11] . These key inflammatory cytokines are produced from macrophages, neutrophils and endothelial cells [46] . These cytokines are able to exacerbate the disease activity by triggering other inflammatory cytokines [10] . TNF-α plays an important role in apoptosis of enterocytes, and diarrhea most probably results from IL-1β activity [45] . Thus blocking production or activity of these cytokines should be helpful. Infliximab, an anti-TNF-α treatment, is widely used in the management of IBD [47, 48] . Previous studies have shown an elevation in level of these cytokines in TNBS-induced model of colitis. Our results show that silymarin is able to reduce TNF-α and IL-1β levels in colonic tissue probably through inhibition of their production or activity. Other investigations confirm such traits for silymarin [26, 35] . Inhibition of these major cytokines can lead to the prevention of a detrimental rise in other inflammatory and toxic stress mediators.
In the inflammatory condition, infiltration of immune cells to the site of inflammation, leads to the production of a large amount of harmful components including ROS. ROS contribute to oxidative damages to various cellular components resulting in cell death or apoptosis. Oxidative stress is mainly involved in the pathogenesis of IBD [49] . This condition, which is the consequence of an imbalance between production of oxidative components and anti-oxidant defence system, develops during the course of inflammation [4] . In order to assess the antioxidant power in colonic tissue samples, the FRAP method was used. Our results showed that anti-oxidant power of colonic tissue decreased significantly following injury. This evidence confirms the role of toxic stress as a contributing factor in developing IBD. According to our results, silymarin is able to enhance total anti-oxidant capacity of tissue in a dose dependent manner. This finding confirms previous evidence of the anti-oxidant effects of silymarin. As mentioned before, this property may be due to its ability to scavenging free radicals and increase the activity of anti-oxidant enzymes.
In addition to macromolecules oxidation, free radicals and ROS in the inflamed tissue can attract variety of immune cells to the site of inflammation [11] . Polymorphonuclear neutrophils are a group of these cells and their sequestration to the inflamed tissue leads to the overexpression of various inflammatory components, including proinflammatory cytokines (such as IL-1β, IL-6, IL-8 and TNF-α), adhesion molecules, prostaglandins, leukoterienes and platelet-activating factor [50] . Furthermore, the activated neutrophils consume a large amount of oxygen unexpectedly, which leads to the production of more ROS and overexpression of oxidative enzymes like MPO. MPO is located in the granules of neutrophils and its level and activity have been extremely useful as a marker of neutrophil infiltration to the site of inflammation in both human and experimental models of IBD [51] . According to our results, silymarin reduced MPO activity significantly in rat colitis. This finding confirms its ability to diminish neutrophil penetration to the inflamed tissue and consequently prevent release of damaging components that could exacerbate the inflammatory condition.
Lipid peroxidation is a reaction which leads to the production of free radicals such as peroxy radicals in cells and tissues. In fact, lipid peroxidation can potentiate the primary site of injury, initiated by free radicals [26] . It has been shown that TBARS levels significantly enhance in the inflamed intestinal mucosa of patients suffering from IBD [52] . Also, other investigations have shown an increase in its levels in the colonic samples of animals with TNBS-induced colitis. Results of the TBARS assay in colonic tissue revealed that silymarin attenuates colonic damage by down-regulating the lipid peroxidation process, confirming previous findings on the anti-oxidant properties of silymarin [26, 33] . It likely exerts this effect through its ability to antagonize free radical production and activity, and maintaining a balance between oxidants and anti-oxidants. As mentioned before, researches demonstrate that silymarin not only has free radical scavenging abilities, but also enhances the activity of anti-oxidant enzymes [26] . Finally, TNF-α level, which is an important contributing factor of lipid peroxidation, was reduced by administration of silymarin, suggesting another mechanism against lipid peroxidation.
As mentioned before, silymarin is able to inhibit NF-κB activity. NF-κB regulates the expression of important rapid-acting genes involved in the inflammatory response. Colonic biopsies of patients with active IBD shows elevated NF-κB activity. Therefore, the protective effects of silymarin observed in this study may be partially due to NF-κB inhibition [35] .
Several animal and clinical studies have confirmed safety of silymarin even at high doses (more than 1500 mg/day). The incidence of side effects is very low and they are mostly limited to some gastrointestinal symptoms like bloating and dyspepsia [25] . Supporting the present data, silymarin has been found to have positive effects in the acute stage of a rat model of colitis in comparison to sulfasalazine [53] , when tested in doses different to the present doses and measuring other biomarkers like colonic glutathione.
In conclusion, the present study elucidated the beneficial effects of silymarin, an extract of Silybum marianum (milk thistle) seeds, on a murine model of colitis. Silymarin effectively reduced colonic damage, lipid peroxidation, neutrophil infiltration and the content of inflammatory cytokines alongside increasing total antioxidant capacity of colonic tissue. The protective effect seen herein confirms the previous reports on the antiinflammatory and anti-oxidative properties of silymarin. Since silymarin has been accepted as a safe herbal product with few side effects and low incidence of side effects in therapeutic doses, it may find a place in the management of IBD, although this possibility requires further investigations to elucidate mechanisms involved in protective effects of silymarin in IBD.
